<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>[REDACTED] Progress Note</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Assessment</a></li><li><a href="#id2">Allergies and Adverse Reactions</a></li><li><a href="#id3">Plan</a></li><li><a href="#id4">Reason for Visit</a></li><li><a href="#id5">Encounters</a></li><li><a href="#id6">Immunizations</a></li><li><a href="#id7">Diagnostic Results</a></li><li><a href="#id8">Medications</a></li><li><a href="#id9">Problems</a></li><li><a href="#id10">Vital Signs</a></li><li><a href="#id11">Notes Section</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Assessment</a></h3><div>See Clinical Notes section</div><h3><a name="id2" href="#toc">Allergies and Adverse Reactions</a></h3><div><table>
    <thead>
        <tr>
                            <th>Medication/Group Name</th>
                <th>Reaction</th>
                <th>Severity</th>
                <th>Date</th>
        </tr>
    </thead>
    <tbody>
                <tr ID="AlertOBS-1000">
                            <td>ciprofloxacin</td>
                            <td/>
                            <td/>
                            <td>[REDACTED]</td>
                </tr>
    </tbody>
</table>
</div><h3><a name="id3" href="#toc">Plan</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="CarePlanRef-1001">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 30 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1002">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>LAB 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1003">
						<td>[REDACTED]</td>
						<td>APPOINTMENT</td>
						<td>OV 30 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1004">
						<td>[REDACTED]</td>
						<td>LABORDER</td>
						<td>Mammogram, 3D w/ tomosynthesis, diagnostic</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id4" href="#toc">Reason for Visit</a></h3><div>OV 30 MIN</div><h3><a name="id5" href="#toc">Encounters</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="EncounterDiagnosisRef-1005">
							<td>[REDACTED]</td>
							<td>Neutropenia (finding)</td>						
					</tr>
	</tbody>
</table>
</div><h3><a name="id6" href="#toc">Immunizations</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Instructions</th>
				<th>Refusal Reason</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
				<tr><td colspan="7">No data for this encounter</td></tr>
	</tbody>
</table>
</div><h3><a name="id7" href="#toc">Diagnostic Results</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Test</th>
				<th>Units</th>
				<th>Lower Limit</th>
				<th>Upper Limit</th>
				<th>Result</th>
				<th>Flag</th>
				<th>Comments</th>
				<th>Status</th>
				<th>Ordered By</th>
				<th>Specimen Source</th>
				<th>Lab Address</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ResultOBS-1006">
						<td>[REDACTED]</td>
						<td/>
						<td>DEXA</td>
						<td/>
						<td/>
						<td/>
						<td>Radiology Ltd. - [REDACTED]
[REDACTED][REDACTED]
[REDACTED]
Phone: [REDACTED]

NAME:  [REDACTED]:  [REDACTED]
MRN:  [REDACTED]
ACC:  RA12623424

FINAL REPORT
 BONE DENSITY EVALUATION: [REDACTED]

CLINICAL DATA: The indication for this evaluation of treatment for the prevention/monitoring of osteoporosis.

RISK FACTORS: Post Menopausal.

DISEASE HISTORY: Cancer history.

FINDINGS:
On [REDACTED] we performed bone density scans on your patient, [REDACTED].  Current  studies were performed using a HOLOGIC unit.  Please refer to images for prior measurements.

BONE DENSITY MEASUREMENTS:

                           BMD       T-Score      %Young      Z-Score      %Age
   Date             gm/cm2       Ref             Match            Ref           Match       Body Part
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
[REDACTED]       0.630         -2.00             74.0%          0.20         103.0%     Left Femoral Neck
[REDACTED]       0.773         -1.40             82.0%          0.50         108.0%     Left Total hip
[REDACTED]       0.806         -2.20             77.0%          0.30         104.0%     AP Total spine

FRAX 10 year probability of major osteoporotic fracture is 13% and hip fracture is 3.4%.

"Z-Scores" represent the Standard Deviations above and below the mean for age-matched BMD.  Please note that T-Score values are important in determining increased risk for fractures.  The T-Score represents the Standard Deviations above or below the mean BMD for young normals.  With each "(-)1" Standard Deviation decrease in bone density, the risk for fracture doubles exponentially(i.e. T-Score of (-)1.0 will double the risk and (-)2.0 will be 4 times the risk).  A T-Score of (-)1.1 to (-)2.49 indicates increasing degrees of OSTEOPENIA, and less than or equal to (-)2.5 is consistent with OSTEOPOROSIS.

IMPRESSION: OSTEOPENIA
Scan of Left Femoral Neck indicates osteopenia.
Scan of Left Total hip indicates osteopenia.
Scan of AP Total spine indicates osteopenia.

Patient is at medium risk for fracture.  There has been a significant REDUCTION in bone mineral density of the HIP since the prior study.

BONE DENSITY IS LOW AT ONE OR MORE SKELETAL SITES. THE PATIENT'S BMD AND CLINICAL RISK FACTORS CONTRIBUTE TO THIS PATIENT'S HIGH RISK OF FRACTURE.

This patient's lowest T-score is low at one or more skeletal sites.  It meets the World Health Organization's (WHO) criteria for ?low bone mass? (T-score between -1.0 and -2.5).

The patient's 10-year risk of hip fracture as calculated by FRAX exceeds the threshold where pharmacological therapy is recommended by the National Osteoporosis Foundation (NOF).

The National Osteoporosis Foundation Guide recommends that FDA-approved medical therapies be considered in postmenopausal women and men aged = [REDACTED] years with a:
?Hip or vertebral fracture
?T-score of = -2.5 at the spine or hip
?Ten-year fracture probability by FRAX of = 20% for major osteoporotic fracture or = 3% for hip fracture.

However, all treatment decisions require clinical judgment and consideration of individual patient factors, including patient preferences, comorbidities, previous drug use, risk factors not captured in the FRAX model (e.g., frailty, falls, vitamin D deficiency, increased bone turnover, interval significant decline in bone density) and possible under or overestimation of fracture risk by FRAX.


Electronically signed by:
[REDACTED] MD
bw/penrad:[REDACTED] 09:31:44</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>[REDACTED]</td>
                        <td/>
                        <td/>
				</tr>
	</tbody>
</table>
</div><h3><a name="id8" href="#toc">Medications</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Frequency</th>
				<th>Instructions</th>
				<th>Start Date</th>
				<th>End Date</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="MedicationOBS-1007">
							<td/>
							<td>Atorvastatin Oral </td>
							<td/>
							<td> </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1008">
							<td/>
							<td>Calcium-Cholecalciferol Oral 600 mg-10 mcg (400 unit) </td>
							<td/>
							<td> </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1009">
							<td>[REDACTED]</td>
							<td>Lamotrigine Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1010">
							<td>[REDACTED]</td>
							<td>Carvedilol Oral 24 hr Cap </td>
							<td>PO</td>
							<td>1.0 CAPSULE, MULTIPHASIC RELEASE 24 HR</td>
							<td>daily</td>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1011">
							<td>[REDACTED]</td>
							<td>Lisinopril Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>[REDACTED]</td>
							<td/>
							<td>active</td>
					</tr>
	</tbody>
</table>
</div><h3><a name="id9" href="#toc">Problems</a></h3><div><table>
	<thead>
		<tr>
							<th>Diagnosis</th>
				<th>Status</th>
				<th>Date of Diagnosis</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ProblemOBS-1012">
						<td>Neutropenia (finding)</td>
						<td>Active</td>
						<td>08/2009</td>
				</tr>
				<tr ID="ProblemOBS-1013">
						<td>Senile osteopenia (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1014">
						<td>Breast cancer, female</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1015">
						<td>Estrogen receptor positive status [ER+] </td>
						<td>Active</td>
						<td>[REDACTED]</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id10" href="#toc">Vital Signs</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="VitalSignsRef-1016">
						<td>[REDACTED]</td>
						<td>
							Body Temperature
							
						</td>
						<td>98.30</td>
				</tr>
				<tr ID="VitalSignsRef-1017">
						<td>[REDACTED]</td>
						<td>
							Heart Beat
							
						</td>
						<td>68.00</td>
				</tr>
				<tr ID="VitalSignsRef-1018">
						<td>[REDACTED]</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>16.00</td>
				</tr>
				<tr ID="VitalSignsRef-1019">
						<td>[REDACTED]</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>95.00</td>
				</tr>
				<tr ID="VitalSignsRef-1020">
						<td>[REDACTED]</td>
						<td>
							BSA
							
						</td>
						<td>1.75</td>
				</tr>
				<tr ID="VitalSignsRef-1021">
						<td>[REDACTED]</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1022">
						<td>[REDACTED]</td>
						<td>
							Weight
							
						</td>
						<td>161.80</td>
				</tr>
				<tr ID="VitalSignsRef-1023">
						<td>[REDACTED]</td>
						<td>
							Height
							
						</td>
						<td>62.00</td>
				</tr>
				<tr ID="VitalSignsRef-1024">
						<td>[REDACTED]</td>
						<td>
							BMI
							
						</td>
						<td>29.59</td>
				</tr>
				<tr ID="VitalSignsRef-1025">
						<td>[REDACTED]</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>129</td>
				</tr>
				<tr ID="VitalSignsRef-1026">
						<td>[REDACTED]</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>73</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id11" href="#toc">Notes Section</a></h3><div>	<ul><li>
		        Follow Up (medonc): 
		        <p>
		        		
<br/>
<br/>
<br/>
<br/>

<br/>LOCATION: [REDACTED] Oncology [REDACTED]<br/>

PATIENT: [REDACTED]

<br/>MRN: [REDACTED]

<br/>DOB: [REDACTED]<br/>
ATTENDING PHYSICIAN: [REDACTED], [REDACTED]<br/>
<br/>


<br/>DATE of SERVICE : [REDACTED]<br/>


<br/>


<br/>REFERRING PHYSICIAN<br/>
<br/>
<br/>REASON FOR VISIT<br/>
Follow up: Left breast cancer. Stage I, cT1N0, left IDC, grade 1, pT1a(3mm) pNx,  ER 100%, PR 90%, Ki-67 5%, HER2 0/DISH non amplified. <br/>
<br/>
<br/>PRINCIPAL DIAGNOSIS<br/>

<ul><li>Neutropenia (finding) ( Date of Dx:8/2009 Disease Status: Evidence of disease; First record:[REDACTED] Last record:[REDACTED] )</li></ul>
<br/>TREATMENT SYNOPSIS<br/>
<br/>


<br/>COMPLETED TREATMENT DETAILS

<br/>Surgeries: Procedure: Defibrillator placement (procedure); Procedure: Cholecystectomy (procedure); [REDACTED], Procedure: Partial mastectomy (procedure); [REDACTED], Procedure: Core needle biopsy of breast (procedure).  . . . . <br/>
<br/>
<br/>HISTORY OF PRESENT ILLNESS<br/>
[REDACTED] is a [REDACTED] female. 
<ul><li>DEXA scan on [REDACTED] indicated osteopenia, T-score -2.10 AP total spine.<br/>
	</li><li>History dates back to 02/2023. She underwent a bilateral screening mammogram at Rad Ltd on [REDACTED] that showed a focal asymmetry in the left breast at 4:00 posterior depth.</li><li>She had a left problem solving mammogram and ultrasound at Rad Ltd on [REDACTED] and this showed a 5 mm hypoechoic oval mass with an indistinct margin at 2:00 middle depth, 7 cm from the nipple.<br/>
	</li><li>She underwent a left ultrasound guided biopsy at Rad Ltd on [REDACTED]. Pathology showed grade 1 IDC, and low grade DCIS. ER &gt;95%, PR 80%, HER2 1+, Ki-67 1-3%. HER2 DISH non-amplified.<br/>
	</li><li>She underwent a left US-guided partial mastectomy with [REDACTED] on [REDACTED]. Final surgical pathology revealed IDC, grade 1, pT1a(3mm) pNx, grade 1 DCIS present 16 mm, all margins negative for DCIS and invasive carcinoma by &gt;10 mm, ER 100%, PR 90%, Ki-67 5%, HER2 0/DISH non amplified.</li><li>She completed radiation therapy from [REDACTED]-[REDACTED]. She received a total of 2,600 cGy in 5 fractions.<br/>
	</li><li>Bilateral diagnostic mammogram [REDACTED] benign.<br/>
	</li></ul>
Interval History:<br/>
I met with her in the clinic [REDACTED] for follow up of previously diagnosed left breast IDC, treated with left partial mastectomy and radiation therapy.  She continues under clinical surveillance after opting to forego adjuvant endocrine therapy.  She was last seen [REDACTED].  Overall, she is doing well.  She denies any new breast concerns.<br/>
<br/>
Bilateral diagnostic mammogram on [REDACTED] showed benign findings.  She will be next due for bilateral mammogram in 11/2024.  Imaging has already been ordered by breast surgery.<br/>
<br/>
DEXA scan completed [REDACTED] indicated osteopenia.  She is next due for DEXA scan in 05/2024.  She continues to take vitamin D daily.<br/>
<br/>
Labs from [REDACTED] were remarkable for creatinine 1.45, eGFR 38, BUN/Creatinine ratio 11 and TSH 5.580, but otherwise unremarkable. CBC was within normal limits.<br/>
<br/>
<br/>
<br/>PAST MEDICAL HISTORY

<br/>
<br/>
<br/>CHF<br/>
Hypertension<br/>
Cardiomyopathy <br/>
Defibrillator in place (left side)<br/>
Hypothyroidism<br/>
Seizures<br/>
Chronic renal impairment<br/>


<br/>
<br/>PAST SURGICAL HISTORY<br/>


Procedure: Defibrillator placement (procedure)<br/>
Procedure: Cholecystectomy (procedure)<br/>
[REDACTED], Procedure: Core needle biopsy of breast (procedure)<br/>
<br/>
<br/>PAST OBGYN HISTORY<br/>
Menses Details: Age of First Menses: 12;<br/>
Pregnancy Details: Currently Pregnant: No; Desire for Fertility: No; Gravida: 2; Para: 2; #Living Children: 2;<br/>
Menopause Information: Postmenopausal; Menopause Age: [REDACTED]; Reason: Natural;<br/>
OB/GYN Medication Hx: Contraceptive Hormonal Use: No; Post-Menopausal Hormonal Therapy: No; IUD: No; Other Contraceptive Hx: No;<br/>
<br/>


<br/>FAMILY HISTORY<br/>
Unknown<br/>
<br/>
<br/>SOCIAL HISTORY<br/>

Never smoker<br/>
<br/>
<br/>ALLERGIES<br/>
ciprofloxacin<br/>
<br/>
<br/>MEDICATIONS<br/>

<ul><li>Carvedilol Oral 24 hr Cap 80 mg capsule, ER multiphase 24 hr 1 CAPSULE, MULTIPHASIC RELEASE 24 HR PO daily</li><li>Calcium 600 + D(3) (Calcium-Cholecalciferol Oral 600 mg-10 mcg (400 unit))</li><li>Atorvastatin Oral 40 mg capsule</li><li>Lamotrigine Oral 100 mg tablet 1 TABLET(S) PO daily</li><li>Lisinopril Oral 5 mg tablet 1 TABLET(S) PO daily</li></ul>
<br/>


<br/>REVIEW OF SYSTEMS<br/>
A complete 10 systems review completed and negative except for those mentioned in the history of present illness or below.<br/>
<br/>
<br/>VITALS/PERFORMANCE STATUS<br/>
PERFORMANCE STATUS: Karnofsky: 100% Normal, no complaints, no evidence of disease. (Date: [REDACTED]) ECOG: NA<br/>
VITAL SIGNS: Blood pressure: 129/73, R arm, Pulse: 68, Temperature: 98.3 F, Respirations: 16, O2 sat: 95%, Pain Scale: 0, Height: 62 in, Weight: 161.8 lb, BSA: 1.75, BMI: 29.59 kg/m2<br/>



<br/>


<br/>
<br/>
<br/>
<br/>PHYSICAL EXAM


Constitutional: Normal appearance, no acute distress.<br/>
Eyes: Conjunctivae normal, eyelids normal, PERRLA, sclerae anicteric.<br/>
Ears, nose, throat: External ears and nose normal, hearing grossly normal, oropharynx unremarkable.<br/>
Neck: Supple, no masses.<br/>
Respiratory: Breathing comfortably, lungs clear to auscultation.<br/>
Cardiovascular: Normal heart sounds, heart rhythm regular, no peripheral edema.<br/>
Left breast: Pacemaker noted in superior aspect of anterior chest, just distal to clavicle.  Healed lumpectomy scar, otherwise normal appearing.  No masses.  No tenderness.<br/>
Right breast: Normal appearance, no masses, no tenderness.<br/>
Abdomen: No masses, no tenderness, no hepatomegaly, no splenomegaly, bowel sounds normal.<br/>
Pelvic: Pelvic exam deferred.<br/>
Rectal: Rectal exam deferred.<br/>
Lymph Nodes: No cervical adenopathy, no axillary adenopathy, no supraclavicular adenopathy.<br/>
Skin: No rash, no petechiae, no ecchymosis, no pallor, no cutaneous nodules.<br/>
Musculoskeletal: Normal muscle strength.<br/>
Neurologic: No focal motor deficit, normal gait, no abnormal mental status.<br/>
Psychiatric: Oriented to person, place, and time, mood and affect appropriate to the situation, appropriate judgment and insight, memory intact.<br/>
<br/>


<br/>LAB<br/>

<table border="1">
	<tbody>
		<tr>
			<th align="left">LabResults</th>
			<td>[REDACTED]</td>
			<td>[REDACTED]</td>
			<td>[REDACTED]</td>
			<td>[REDACTED]</td>
			<td>[REDACTED]</td>
			<td>[REDACTED]</td>
		</tr>
		<tr>
			<th align="left">  Pathology/Cytology</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Pathology report</td>
			<td><br/>
			</td>
			<td>See attached</td>
			<td>See attached; See attached</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Lab - Other</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Lab Report</td>
			<td>See attached</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td>See attached</td>
			<td>See attached</td>
			<td>See attached</td>
		</tr>
	</tbody>
</table>
<br/>
<br/>
<br/>RADIOLOGY<br/>
[REDACTED] Bilateral screening MMG at Rad Ltd:<br/>
Scattered areas of fibroglandular density<br/>
A pacemaker battery pack partially obscures the left axilla<br/>
Negative, BIRADS 1<br/>
<br/>
[REDACTED] Bilateral screening MMG at Rad Ltd:<br/>
Scattered areas of fibroglandular density<br/>
A pacemaker battery pack partially obscures the left axilla<br/>
Negative, BIRADS 1<br/>
<br/>
[REDACTED] Bilateral screening MMG at Rad Ltd:<br/>
Scattered areas of fibroglandular density<br/>
Left- focal asymmetry at 4:00 posterior depth<br/>
Right- negative<br/>
Indeterminate, BIRADS 0<br/>
<br/>
[REDACTED] Left problem solving MMG and US at Rad Ltd:<br/>
Left- 5 mm hypoechoic oval mass with an indistinct margin at 2:00 middle depth, 7 cm from the nipple<br/>
Axilla-negative<br/>
Suspicious of malignancy, BIRADS 4<br/>
<br/>
[REDACTED] Bilateral diagnostic MMG:<br/>
Pacemaker overlies the left axillary region<br/>
There are benign-appearing calcifications in both breasts<br/>
There are also postoperative findings in the left breast<br/>
No significant masses, calcifications, or other findings are seen in either breast<br/>
Benign, BI-RADS 2<br/>
<br/>
<br/>PATHOLOGY<br/>
[REDACTED] Left US guided biopsy at Rad Ltd: (Hydromark)<br/>
IDC, grade 1, no LVI,3 mm<br/>
DCIS, low grade without central necrosis<br/>
ER &gt;95%, PR 80%, HER2 1+, Ki-67 1-3%<br/>
HER2 DISH non-amplified<br/>
<br/>
<br/>OTHER TESTING<br/>


<br/>
<br/>
<br/>PROBLEM LIST<br/>

<ul><li>Neutropenia (finding) ( ICD-10:D70.9 ;Neutropenia, unspecified )</li><li>Breast cancer, female ( ICD-10:C50.412 ;Malignant neoplasm of upper-outer quadrant of left female breast )</li><li>Estrogen receptor positive status [ER+] ( ICD-10:Z17.0 ;Estrogen receptor positive status [ER+] )</li><li>Senile osteopenia (disorder) ( ICD-10:M85.89 ;Other specified disorders of bone density and structure, multiple sites )</li></ul>
<br/>


<br/>DEPRESSION STATUS<br/>
Was screened; Outcome positive: No; Screening Date: [REDACTED]; Screening Tool: Patient Health Questionnaire (PHQ9); Total depression score: 0<br/>
<br/>

<br/>ASSESSMENT<br/>
[REDACTED] is a [REDACTED] postmenopausal female with:

<br/>
<br/>
<br/>
1. Stage I, cT1N0, left IDC, grade 1, pT1a(3mm) pNx,  ER 100%, PR 90%, Ki-67 5%, HER2 0/DISH non amplified. Treated with left partial mastectomy [REDACTED], grade 1 DCIS present 16 mm, all margins negative for DCIS and invasive carcinoma by &gt;10 mm.<br/>
<br/>
She has several good tumor characteristics including small tumor size, strong ER/PR positivity, [REDACTED]-67 and no clinical lymph node involvement. Overall, she has very low risk disease. <br/>
<br/>
She completed radiation therapy from [REDACTED]-[REDACTED]. She received a total of 2,600 cGy in 5 fractions.<br/>
<br/>
We discussed her very reasonable concerns regarding plan for adjuvant antiestrogen and treatment-related side effects. The standard of care is to consider adjuvant endocrine therapy for at least 5 years. Given her age and risk for musculoskeletal side effects affecting her quality of life, she may be unable to tolerate 5 years of adjuvant endocrine therapy. She does have very low risk disease, and has completed adjuvant radiation, which will reduce her risk of local recurrence.  Her risk of distant recurrence is very low.  Out of concerns for side effects,  she would like to forego adjuvant endocrine therapy. I think this is reasonable.  Given T1a disease, her age, and overall magnitude of benefit, adjuvant endocrine will likely add minimal benefit.  Therefore, it is reasonable to forego adjuvant endocrine therapy and continue clinical/imaging surveillance.<br/>
<br/>
She verbalized understanding and would like to proceed with the above plan.  <br/>
<br/>
[REDACTED] on exam [REDACTED].<br/>
<br/>
Follow up [REDACTED] with labs prior to visit including CBC, CMP, and vitamin D.<br/>
<br/>
2. Surveillance plan.  S/p left partial mastectomy [REDACTED]. She will continue on surveillance with annual mammograms. Bilateral diagnostic<br/>
mammogram [REDACTED] benign. <br/>
<br/>
Next bilateral mammogram due 11/2024, this was already ordered by breast surgery.<br/>
<br/>
3. Genetics. No indication for genetic testing. <br/>
<br/>
4. Bone health. DEXA scan on [REDACTED] indicated osteopenia, T-score -2.10 AP total spine.  To take daily calcium and vitamin D.<br/>
<br/>
Next DEXA due 05/2024, this was ordered [REDACTED].<br/>
<br/>
5. Lab review. Labs from [REDACTED] were remarkable for Creatinine 1.45, eGFR 38, BUN/Creatinine ratio 11 and TSH 5.580, but otherwise unremarkable. CBC was within normal limits.<br/>
<br/>
6. Coping. She seems to be coping well.  No issues [REDACTED].  No intervention needed at this time. <br/>
<br/>
Discussion and Follow Up:<br/>
The patient's recent lab and imaging studies were reviewed and interpreted, relevant information was discussed with the patient. The patient expressed understanding and agreement to the above plan. The patient's questions [REDACTED] were answered to their satisfaction. Follow up for treatment. The patient knows to call sooner if any new problems or concerns arise.<br/>


<br/>
<br/>PLAN<br/>
<ol><li>Given T1a disease, her age, and overall magnitude of benefit, adjuvant endocrine will likely add minimal benefit. We will continue clinical surveillance.<br/>
	</li><li>Bilateral diagnostic mammogram due 11/2024, this has already been ordered by breast surgery.<br/>
	</li><li>Next DEXA due 05/2024, order placed [REDACTED].</li><li>To take daily calcium and vitamin D.<br/>
	</li><li>Follow up [REDACTED] with labs prior to visit including CBC, CMP, and vitamin D.<br/>
	</li></ol>
<br/>
Patient has a diagnosis of cancer which requires close monitoring.<br/>
 <br/>
The time spent on this visit includes:<br/>
Preparing to see patient with review of test and or records: 10 minutes<br/>
Ordering medications, tests, procedures: 2 minutes<br/>
Referring and communicating with other healthcare professionals:<br/>
Documenting clinical information in the electronic health record: 10 minutes<br/>
Independently interpreting results (not separately reported) to patient/family/caregiver:<br/>
Care coordination:<br/>
Time spent with patient: 10 minutes<br/>
Total time: 32 minutes<br/>
  <br/>
Thank you very much for allowing us to participate in the care of this patient. Please do not hesitate to contact us with any questions or concerns.<br/>
My warmest regards,<br/>
[REDACTED], [REDACTED]-C<br/>
[REDACTED] Oncology<br/>
<br/>
<br/>NEW ORDERS<br/>
Imaging
<ul><li>[REDACTED], DEXA scan, Instructions: due 05/2024, Perform Date: Per Instruction</li></ul>
<br/>
Labs
<ul><li>[REDACTED], CBC w/ auto diff, Perform Date: Prior to Next Visit</li><li>[REDACTED], CMP, Perform Date: Prior to Next Visit</li><li>[REDACTED], Vitamin D, 25-Hydroxy panel, Perform Date: Prior to Next Visit</li></ul>
<br/>
Services
<ul><li>[REDACTED], RTC APP, Perform Date: 6 Months</li><li>[REDACTED], RTC labs, Perform Date: Prior to Next Visit</li></ul>
<br/>
<br/>
<br/>.<br/>
<br/>
[REDACTED] PA<br/>


<br/>
Send copy of note to: <br/>
   <br/>
<br/>
<br/>
<br/>

<br/>Electronically signed by [REDACTED] PA [REDACTED] 12:37 MST 
		        </p>
		      </li></ul>
</div><br/><br/>
</body></html>